Natural biocon (India) Limited has formally notified BSE Limited about its upcoming board meeting scheduled for April 30, 2026. The meeting will be held at the company's registered office to deliberate on crucial financial matters for the concluded financial year.

Board Meeting Agenda

The primary agenda for the board meeting includes comprehensive review and approval of key financial documents. The directors will consider and approve the audited financial results for both the quarter and financial year that ended on March 31, 2026.

Regulatory Compliance

The board meeting intimation has been issued in strict compliance with Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The meeting will also address the auditor's report and certificate for unmodified opinion pursuant to Regulation 33 of the same SEBI regulations.

The agenda includes consideration of related party transactions, ensuring comprehensive disclosure and transparency in accordance with regulatory requirements. An additional provision has been made for any other business items that may arise with the chairman's permission.

Company Leadership

The intimation was digitally signed by Arunkumar Dashrathbhai Prajapati, Managing Director of Natural Biocon (India) Limited, bearing DIN 08281232. The document was signed on April 22, 2026, and formally communicated to the General Manager Corporation Relationship Department at BSE Limited.

The company's registered office is located at A-1007, Sankalp Iconic Tower, opposite Vikram Nagar, Iscon Temple Cross Road, S.G. Highway, Ahmedabad 380054, Gujarat, India. Natural Biocon (India) Limited operates under CIN L24299GJ1992PLC018210 and is listed on BSE with script code 543207.

Natural biocon (India) Limited has submitted its quarterly compliance certificate to BSE Limited, fulfilling regulatory requirements under SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended March 31, 2026.

Regulatory Compliance Submission

The company filed the mandatory certificate under Regulation 74(5) of SEBI Depositories Regulations on April 06, 2026. Managing Director Arunkumar Dashrathbhai Prajapati digitally signed the submission, confirming the company's adherence to regulatory protocols for the fourth quarter of FY26.

Registrar Confirmation

MCS Share Transfer Agent Limited, serving as the company's Registrar and Transfer Agent, provided the confirmation certificate dated April 2, 2026. The registrar certified that all securities received from depository participants for dematerialisation during Q4FY26 were properly processed and confirmed to depositories.

The registrar confirmed compliance with key regulatory requirements:

• Securities received for dematerialisation were accepted or rejected as appropriate
• All securities have been listed on stock exchanges where earlier issued securities are listed
• Security certificates received for dematerialisation were mutilated and cancelled after verification
• Depository names were substituted in the register of members within the mandated 15-day period

Corporate Information

Natural Biocon (India) Limited operates from its registered office at A-1007, Sankalp Iconic Tower, S.G. Highway, Ahmedabad, Gujarat. The company maintains its corporate identification number L24299GJ1992PLC018210 and GST registration 24AAACN6841KIZD.

The quarterly compliance certificate demonstrates the company's commitment to maintaining proper dematerialisation processes and regulatory adherence as required under SEBI guidelines for listed entities.